CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
Mecwins developed the AVAC Technology, a prototype for early detection of sepsis. It offers ultra-sensitive diagnostics with rapid results, requiring smaller samples and capable of analyzing multiple biomarkers simultaneously, aiming to improve patient outcomes in critical care settings.
More than 27 M people per year develop sepsis, which has been catalogued as a Global health problem & priority.
Sepsis kills more people than AIDs, prostate and breast cancer combined globally, and it lack of appropriate diagnostic tools.
Moreover it has been demonstrated that early detection during the first hours is crucial for survival.
Mecwins has developed the AVAC Technology prototype, an ultrasensitive detection equipment for early detection of sepsis, with: i) sensitivity a million tim…
MECWINS SA
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
